ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,975.38
0.55%
US Tech 100
21,002.00
1.25%
Dow Jones
42,706.56
-0.06%
Brent Oil
76.07
-0.57%
Bitcoin
102,022.53
3.76%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU
  6. Pharming Group NV (PHARM)

  7. Pharming Group NV (PHARM) News

PHARM

Pharming Group NV (PHARM)

Pharming Group NV
Date:
Sort by:
 Showing the most relevant articles for your search:EU:PHARM
DateTimeSourceHeadlineSymbolCompany
12/15/20241:45PMGlobeNewswire Inc.Pharming announces public cash offer to the shareholders of Abliva ABEU:PHARMPharming Group NV
12/11/20241:00AMGlobeNewswire Inc.Pharming announces positive topline data in pediatric clinical trial of leniolisibEU:PHARMPharming Group NV
11/05/20242:00AMGlobeNewswire Inc.Pharming Group to participate in November investor conferenceEU:PHARMPharming Group NV
10/24/20241:00AMGlobeNewswire Inc.Pharming Group reports third quarter 2024 financial results and provides business updateEU:PHARMPharming Group NV
10/10/20242:00AMGlobeNewswire Inc.Pharming Group to report third quarter 2024 financial results on October 24EU:PHARMPharming Group NV
10/10/20241:00AMGlobeNewswire Inc.Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulationEU:PHARMPharming Group NV
09/26/20241:00AMGlobeNewswire Inc.Pharming announces marketing authorization in the U.K. for Joenja® (leniolisib)EU:PHARMPharming Group NV
09/04/20241:00AMGlobeNewswire Inc.Pharming Group to participate in September investor conferencesEU:PHARMPharming Group NV
08/01/20241:00AMGlobeNewswire Inc.Pharming Group reports second quarter and first half 2024 financial results and provides business updateEU:PHARMPharming Group NV
07/18/20242:00AMGlobeNewswire Inc.Pharming Group to report second quarter and first half 2024 financial results on August 1EU:PHARMPharming Group NV
06/03/20242:00AMGlobeNewswire Inc.Pharming Group to participate in June investor conferencesEU:PHARMPharming Group NV
06/03/20242:00AMGlobeNewswire Inc.Pharming Group to participate in June investor conferencesEU:PHARMPharming Group NV
05/30/20244:44PMGlobeNewswire Inc.Pharming Group provides update on ongoing regulatory review of leniolisib for the treatment of APDS in the European UnionEU:PHARMPharming Group NV
05/21/202411:30AMGlobeNewswire Inc.Pharming Group reports on results of the 2024 Annual General Meeting of ShareholdersEU:PHARMPharming Group NV
05/21/202411:30AMGlobeNewswire Inc.Pharming Group reports on results of the 2024 Annual General Meeting of ShareholdersEU:PHARMPharming Group NV
05/20/20242:00AMGlobeNewswire Inc.Pharming Group to participate in May investor conferenceEU:PHARMPharming Group NV
05/20/20242:00AMGlobeNewswire Inc.Pharming Group to participate in May investor conferenceEU:PHARMPharming Group NV
05/15/20241:00AMGlobeNewswire Inc.Pharming Group announces the early redemption of the remaining outstanding €125 million convertible bonds due 2025EU:PHARMPharming Group NV
05/08/20241:00AMGlobeNewswire Inc.Pharming Group reports first quarter 2024 financial results and provides business updateEU:PHARMPharming Group NV
05/08/20241:00AMGlobeNewswire Inc.Pharming Group reports first quarter 2024 financial results and provides business updateEU:PHARMPharming Group NV
04/24/20242:00AMGlobeNewswire Inc.Pharming Group to report first quarter 2024 financial results on May 8EU:PHARMPharming Group NV
04/24/20241:00AMGlobeNewswire Inc.Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact AwardsEU:PHARMPharming Group NV
04/24/20241:00AMGlobeNewswire Inc.Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact AwardsEU:PHARMPharming Group NV
04/19/202412:43PMGlobeNewswire Inc.Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025EU:PHARMPharming Group NV
04/18/20249:04AMGlobeNewswire Inc.Pharming Group announces the placement of €100 million convertible bonds due 2029EU:PHARMPharming Group NV
04/18/20242:00AMGlobeNewswire Inc.Pharming Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025EU:PHARMPharming Group NV
04/08/20241:00AMGlobeNewswire Inc.Pharming announces completion of enrollment in pediatric clinical trial of leniolisibEU:PHARMPharming Group NV
04/08/20241:00AMGlobeNewswire Inc.Pharming announces completion of enrollment in pediatric clinical trial of leniolisibEU:PHARMPharming Group NV
04/04/20242:30AMGlobeNewswire Inc.Pharming Group announces the 2024 Annual General Meeting of ShareholdersEU:PHARMPharming Group NV
04/04/20241:00AMGlobeNewswire Inc.Pharming Group announces the filing of its 2023 Annual Report and Form 20-FEU:PHARMPharming Group NV
 Showing the most relevant articles for your search:EU:PHARM

Your Recent History

USOTC
LEHNQ
Lehman Brothers Financial (CE)
USOTC
TPTW
TPT Global Tech (CE)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
TWOH
Two Hands (PK)
USOTC
PSRU
Valiant Eagle (PK)
USOTC
IQST
iQSTEL (QX)
USOTC
AFFU
Affluence (PK)
USOTC
RDAR
Raadr (PK)
USOTC
FDCT
FDCTech (PK)
USOTC
RDGL
Vivos (QB)
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
RSPI
RespireRx Pharmaceuticals (CE)
USOTC
HMBL
HUMBL (PK)
NYSE
IONQ
IonQ
USOTC
FMCC
Federal Home Loan Mortgage (QB)
USOTC
MONI
Moon Equity (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads